A Phase I, 2-part Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Fasted and Fed Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Dolutegravir/rilpivirine (Primary) ; Dolutegravir; Rilpivirine
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 05 Jan 2016 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 07 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 08 Mar 2015 Status changed from not yet recruiting to recruiting according to ClinicalTrials.gov record.